Cytespace Research

Bengaluru, India Founded: 2011 • Age: 15 yrs Minicorn
Site-solutions organization offering its services in India, Africa and Singapore

About Cytespace Research

Cytespace Research is a Healthcare company based in Bengaluru (India) founded in 2011. Site-solutions organization offering its services in India, Africa and Singapore. Cytespace Research has raised $4.7 million across 4 funding rounds from investors including Jacesa Investments, Antelope Summit Investments and Bhavesh Acharya. The company has 1 employees. Cytespace Research was last valued at $11.22 million in May 2013. Its Indian entity Cytespace Research Private Limited reported revenue of β‚Ή93 Lakh. Cytespace Research offers products and services including Site Solutions, Biometric Solutions, Clinical Data Management, and Biostatistics. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services.

Company details

Cytespace Research offers a range of site-related services to bio-pharmaceutical sponsors and CROs. They partner with networks of hospitals, doctors, and patients, create scalable technology platforms to access clinical research sites and patient networks in emerging markets, and deploy best-in-class clinical research site solutions for the conduct of efficient, predictable, auditable and ethical clinical trials. They offer trial solutions such as feasibility studies, regulatory services, supply chain solutions, and site solutions such as site start-up, trial management, patient recruitment and retention.

  • Headquarters Bengaluru, India
  • Employees 1
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cytespace.com
  • Social LinkedIn
  • Legal Name Cytespace Research Private Limited
  • Date of Incorporation 11 Mar, 2011
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹93 Lakh

    FY 2025 · -34% YoY

  • Net Loss
    -₹1.92 Cr

    FY 2025 · -207% margin

  • EBITDA
    -₹1.90 Cr

    FY 2025 · -205% margin

  • Total Equity Funding
    $4.7M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.49M (USD), Series A

    May 2013

  • Investors
  • Employee Count
    1

Products & Services of Cytespace Research

Cytespace Research offers a comprehensive portfolio of products and services, including Site Solutions, Biometric Solutions, Clinical Data Management, and Biostatistics.

Site Solutions
Site Management

Platform for efficient clinical trial site management and recruitment.

Biometric Solutions
Data Services

Services for EDC and verifiable clinical data processing.

Clinical Data Management
Data Analysis

Tools for managing and analyzing clinical trial data securely.

Biostatistics
Statistical Services

Statistical programming and analysis for clinical research studies.

Funding Insights of Cytespace Research

Cytespace Research has successfully raised a total of $4.7M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.49 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.7M
  • Total Rounds 4
  • Last Round Series A β€” $1.49M
  • First Round $1.02M

    (Sep 2011)

  • Investors Count 10

All 4 funding rounds of Cytespace Research with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2013$1.49MSeries A$11.22MJacesa Investments
–
Oct 2012$1.64MSeries A$9.34MAntelope Summit Investments
May 2012$550,914Seed$β€’β€’β€’β€’β€’Antelope Summit Investments
Sep 2011$1.02MSeed$β€’β€’β€’β€’β€’Endeavour Financial, Oppel Greeff
Valuation history
DateValuationStage
May 2013$11.22Mβ€’β€’β€’β€’β€’β€’β€’β€’
Oct 2012$9.34Mβ€’β€’β€’β€’β€’β€’β€’β€’
May 2012$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Sep 2011$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of Cytespace Research

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $11.22M (May 2013). 10 investors in total: 3 institutional and 7 angel.

Investors in Cytespace Research

Cytespace Research has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Jacesa Investments, Antelope Summit Investments and Bhavesh Acharya.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Seed-stage investments are targeted by Jacesa Investments venture capital firm.
jacesainvestments.tcc.modeZug, Switzerland
Venture capital is provided to tech startups by the fund.
antelopesummitinvestments.tcc.modeRoad Town, British Virgin Islands
Middle-market investment banking services are focused on the mining sector.
endeavourfinancial.comLondon, United Kingdom

Bhavesh Acharya

Angel investor and entrepreneur, focused on early-stage Indian startups.
unknown_43be5ffa69b54600a

Oppel Greeff

unknown_0c77dcc0504f4d6e8

Vikas Shah

unknown_68e5a7927d8e4c47b

Koranchath Jayashankar

unknown_544b2cb7458646b6b

Narges Mahaluxmivala

unknown_b30129e27a0f4892a

Ferzaan Engineer

Co-founder of Cytecare Hospitals, angel investor in healthcare and tech startups
unknown_4bb7f36101e34d0b9

Lalit Pai

Angel investor, ex-entrepreneur, focused on early-stage Indian startups
unknown_2f942dbe0b1c4e9fb
Premium access

Investor details for Cytespace Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Cytespace Research Private Limited (Cytespace Research)

Cytespace Research Private Limited is the primary company behind Cytespace Research. The board of Cytespace Research Private Limited currently have 6 directors; the longest-serving is Suresh Ramu, appointed in 2011. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Suresh Ramu
DIN 00240963
Director11 Mar 201115 yrs 7 moCytespace Research Private Limited
Himanshu Madhusudan Shah
DIN 00025793
Director11 Mar 201115 yrs 7 moCytespace Research Private Limited
Gerardus Adrianus Hoogland
DIN 06673807
Director01 Nov 201312 yrs 11 moCytespace Research Private Limited
Ferzaan Nariman Engineer
DIN 00025758
Director01 Apr 201412 yrs 6 moCytespace Research Private Limited
Gillian Margaret Morrow Corken
DIN 06940674
Director01 Sep 201412 yrs 1 moCytespace Research Private Limited
Oppel Bernhardt Wilhelm Greeff
DIN 07252369
Director03 Aug 201511 yrs 2 moCytespace Research Private Limited

People of Cytespace Research

5 people are tracked at Cytespace Research (3 in leadership, 2 in team); the tracked headcount is 1.

NameRoleGroup
CEOLeadership
Bhavesh Acharya
COOLeadership
Co-founder And CFOLeadership
Rashim Sharma
Site Solution ExecutiveTeam
Gaurav Gupta
Site Solution ExecutiveTeam
Premium access

Complete people profiles for Cytespace Research

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Cytespace Research

Figures of Cytespace Research Private Limited, the primary company behind Cytespace Research, for FY 2025. Revenue was ₹93 Lakh (-34% year on year). Net loss was -₹1.92 Cr (-207% margin). EBITDA was -₹1.90 Cr (-205% margin). Revenue has grown at a compounded annual rate of -46% over three years and -44% over five years.

  • ₹93 LakhRevenue · FY 2025 · -34% YoY
  • -₹1.92 CrNet loss · -207% margin
  • -₹1.90 CrEBITDA · -205% margin
  • ₹4.3 LakhPaid-up capital
  • 1Employees (provident fund records)
  • -46%Revenue CAGR, 3 years
  • -44%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cytespace Research Private Limited are on its company page.

Premium access

Detailed financial statements for Cytespace Research

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Cytespace Research

4 dated milestones of Cytespace Research across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cytespace Research is founded.
  2. Funding First funding round of $1.0M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series A, of $1.5M.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Cytespace Research (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cytespace Research

Cytespace Research was founded in 2011.

Cytespace Research is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Cytespace Research is a funded company, having raised a total of $4.7M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.02M, raised on Sep 2011.

Cytespace Research has 1 employees.

The primary company behind Cytespace Research, Cytespace Research Private Limited, reported revenue of β‚Ή93 Lakh for FY 2025, down 34% year on year.

Cytespace Research offers a range of site-related services to bio-pharmaceutical sponsors and CROs. They partner with networks of hospitals, doctors, and patients, create scalable technology platforms to access clinical research sites and patient networks in emerging markets, and deploy best-in-class clinical research site solutions for the conduct of efficient, predictable, auditable and ethical clinical trials. They offer trial solutions such as feasibility studies, regulatory services, supply chain solutions, and site solutions such as site start-up, trial management, patient recruitment and retention.

Cytespace Research offers Site Solutions, Biometric Solutions, Clinical Data Management, and Biostatistics.

Cytespace Research has 10 investors. Key investors include Jacesa Investments, Antelope Summit Investments, Bhavesh Acharya, Endeavour Financial, and Oppel Greeff.

The valuation of Cytespace Research is $11.22M as of May 2013.

Cytespace Research operates through Cytespace Research Private Limited.

The legal entities of Cytespace Research currently have 6 directors, including Gerardus Adrianus Hoogland, Suresh Ramu, Ferzaan Nariman Engineer and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available